Musialek Piotr, Nizankowski Rafal, Hopkins L Nelson, Micari Antonio, Alvarez Carlos Alejandro, Nikas Dimitrios N, Ruzsa Zoltán, Kühn Anna Luisa, Petrov Ivo, Politi Maria, Pillai Sanjay, Papanagiotou Panagiotis, Mathias Klaus, Sievert Horst, Grunwald Iris Q
Department of Cardiac and Vascular Diseases, Jagiellonian University, John Paul II Hospital, Krakow, Poland.
Accreditation Council, National Centre for Health Quality Assessment, Krakow, Poland.
Postepy Kardiol Interwencyjnej. 2021 Sep;17(3):245-250. doi: 10.5114/aic.2021.109832. Epub 2021 Oct 20.
Stroke, a vascular disease of the brain, is the #1 cause of disability and a major cause of death worldwide. Stroke has a major negative impact on the life of stroke-affected individuals, their families and the society. A significant proportion of stroke victims indicate that would have preferred death over their after-stroke quality of life. Mechanical thrombectomy (MT), opening the occluded artery using mechanical aspiration or a thrombus-entrapment device, is a guideline-mandated (class I, level of evidence A) treatment modality in patients with large vessel occlusion stroke. MT clinical benefit magnitude indicates that a universal access to this treatment strategy should be the standard of care. Today there is a substantial geographic variation in MT deliverability, with large-scale disparities in MT implementation. In many countries effective access to MT remains severely limited. In addition, many of the MT-treated patients are treated too late for a good functional outcome because of logistic delays that include transportations to remotely located, scarce, comprehensive stroke centres. Position Paper from the European Society of Cardiology Council on Stroke and European Association for Percutaneous Cardiovascular Interventions on interdisciplinary management of acute ischaemic stroke, developed with the support of the European Board of Neurointervention fills an important gap in systematically enabling interventional cardiologists to support stroke intervention in the geographic areas of unmet needs in particular. We review strengths and weaknesses of the document, and suggest directions for the next steps that are swiftly needed to deliver MT to stroke patients more effectively.
中风是一种脑部血管疾病,是全球致残的首要原因和主要死因。中风对中风患者及其家庭和社会的生活产生重大负面影响。相当一部分中风患者表示,与其中风后的生活质量相比,他们宁愿选择死亡。机械取栓术(MT)是指使用机械抽吸或血栓捕获装置开通闭塞动脉,是大血管闭塞性中风患者指南规定的(I类,证据水平A)治疗方式。MT的临床获益程度表明,普遍采用这种治疗策略应成为护理标准。如今,MT的可实施性在地域上存在很大差异,MT的实施存在大规模差异。在许多国家,有效获得MT的机会仍然严重受限。此外,由于包括转运至偏远、稀缺的综合卒中中心等后勤延误,许多接受MT治疗的患者接受治疗的时间过晚,无法获得良好的功能结局。由欧洲心脏病学会卒中委员会和欧洲经皮心血管介入协会制定的关于急性缺血性中风跨学科管理的立场文件,在欧洲神经介入委员会的支持下完成,尤其在系统地使介入心脏病专家能够在未满足需求的地理区域支持中风干预方面填补了一个重要空白。我们回顾了该文件的优缺点,并为更有效地为中风患者提供MT而迅速需要采取的下一步措施提出了方向。